Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses. (Q30204646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

Radboud J Duintjer Tebbens

1 March 2020

series ordinal

3

object named as

Radboud J Duintjer Tebbens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

2

Dominika A Kalkowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

18 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1568-1577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25701673%20AND%20SRC:MED&resulttype=core&format=json

Insidious reintroduction of wild poliovirus into Israel, 2013.

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling population immunity to support efforts to end the transmission of live polioviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Preeradication vaccine policy options for poliovirus infection and disease control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Expert review on poliovirus immunity and transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling the dynamics of oral poliovirus vaccine cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

The potential impact of expanding target age groups for polio immunization campaigns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Large ongoing measles outbreak in a religious community in the Netherlands since May 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Retrospective cost-effectiveness analyses for polio vaccination in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Decision analysis in planning for a polio outbreak in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

Vaccine policy changes and epidemiology of poliomyelitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.02.013

The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25701673

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25701673

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25701673